Search research articles
Contact Us
Filters
Showing results (1-10 of 103) with videos related to
Page
of 11
Sort By:
European Journal of Neurology
|
October 26, 2005
Hass J, Firzlaff M (2005). Twenty-four-month comparison of immunomodulatory treatments--a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone). European Journal of Neurology 12:425-431
J Hasford
Journal of Cardiovascular Pharmacology
|
January 1, 1992
Compliance and the benefit/risk relationship of antihypertensive treatment
J Hasford
Infection
|
January 1, 1987
Risk-benefit analyses of drugs: fundamental considerations and requirements from the point of view of the biometrician. Problems in the assessment of the combination of trimethoprim with sulfamethoxazole
J Hasford, N Victor
European Journal of Clinical Pharmacology
|
March 27, 1998
Company observational post-marketing studies: drug risk assessment and drug research in special populations--a study-based analysis
J Hasford, T Lamprecht
Controlled Clinical Trials
|
August 1, 1991
Evaluating quality-of-life measures for clinical trials in Germany
M Bullinger, J Hasford
International Journal of Clinical Pharmacology and Therapeutics
|
February 10, 1998
The PEGASUS project--a prospective cohort study for the investigation of drug use in pregnancy. PEGASUS Study Group
C Irl, J Hasford
Statistics in Medicine
|
December 1, 1992
24-hour blood pressure measurement in antihypertensive drug trials: data requirements and methods of analysis
D Dickson, J Hasford
Drug Safety
|
March 30, 2000
Assessing the safety of drugs in pregnancy: the role of prospective cohort studies
C Irl, J Hasford
British Journal of Haematology
|
July 27, 2001
Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon: comments
M Pfirrmann, J Hasford
Methods of Information in Medicine
|
December 14, 2005
A simulation study using validated prognostic factors to assess expected long-term survival
M Pfirrmann, J Hasford
Page
of 11
Search research articles
Search
Showing results (1-10 of 103) with videos related to
Sort By:
Page
of 11
European Journal of Neurology
|
October 26, 2005
Hass J, Firzlaff M (2005). Twenty-four-month comparison of immunomodulatory treatments--a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone). European Journal of Neurology 12:425-431
J Hasford
Journal of Cardiovascular Pharmacology
|
January 1, 1992
Compliance and the benefit/risk relationship of antihypertensive treatment
J Hasford
Infection
|
January 1, 1987
Risk-benefit analyses of drugs: fundamental considerations and requirements from the point of view of the biometrician. Problems in the assessment of the combination of trimethoprim with sulfamethoxazole
J Hasford, N Victor
European Journal of Clinical Pharmacology
|
March 27, 1998
Company observational post-marketing studies: drug risk assessment and drug research in special populations--a study-based analysis
J Hasford, T Lamprecht
Controlled Clinical Trials
|
August 1, 1991
Evaluating quality-of-life measures for clinical trials in Germany
M Bullinger, J Hasford
International Journal of Clinical Pharmacology and Therapeutics
|
February 10, 1998
The PEGASUS project--a prospective cohort study for the investigation of drug use in pregnancy. PEGASUS Study Group
C Irl, J Hasford
Statistics in Medicine
|
December 1, 1992
24-hour blood pressure measurement in antihypertensive drug trials: data requirements and methods of analysis
D Dickson, J Hasford
Drug Safety
|
March 30, 2000
Assessing the safety of drugs in pregnancy: the role of prospective cohort studies
C Irl, J Hasford
British Journal of Haematology
|
July 27, 2001
Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon: comments
M Pfirrmann, J Hasford
Methods of Information in Medicine
|
December 14, 2005
A simulation study using validated prognostic factors to assess expected long-term survival
M Pfirrmann, J Hasford
Page
of 11